Ferric citrate-derived N-doped hierarchical porous carbons for oxygen reduction reaction and electrochemical supercapacitors
Sign Up to like & getrecommendations! Published in 2017 at "Carbon"
DOI: 10.1016/j.carbon.2016.12.084
Abstract: Abstract This work reports a facile strategy for the preparation of Nitrogen-doped porous carbons via carbonization of a mixture containing ferric citrate (FC) and ammonium chloride (NH4Cl). FC provides carbon and iron element sources, while… read more here.
Keywords: hierarchical porous; citrate; ferric citrate; porous carbons ... See more keywords
The ins and outs of ferric citrate.
Sign Up to like & getrecommendations! Published in 2022 at "Kidney international"
DOI: 10.1016/j.kint.2021.12.032
Abstract: Ferric citrate is used clinically for the treatment of hyperphosphatemia in patients with chronic kidney disease and is approved as an oral iron replacement product for patients with iron-deficiency anemia. In this issue of Kidney… read more here.
Keywords: outs ferric; iron; citrate; ins outs ... See more keywords
P0272COMPARATIVE GUT MICROBIOME DIFFERENCES BETWEEN FERRIC CITRATE AND CALCIUM CARBONATE PHOSPHATE BINDER TREATMENT IN HEMODIALYSIS PATIENTS
Sign Up to like & getrecommendations! Published in 2020 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfaa142.p0272
Abstract: Gut microbiome alteration increases uremic toxin levels inducing chronic inflammation and leading morbidity and mortality in patients with chronic kidney disease. Phosphate-binding agents may potentially change the composition of the gut microbiota. However, the limited… read more here.
Keywords: calcium carbonate; phosphate; ferric citrate;
Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis
Sign Up to like & getrecommendations! Published in 2017 at "Hemodialysis International"
DOI: 10.1111/hdi.12487
Abstract: Introduction: Oral phosphate binders are the main stay of treatment of hyperphosphatemia. Adherence rates to ferric citrate, a recently approved phosphate binder, are unknown. read more here.
Keywords: citrate compared; rates ferric; ferric citrate; adherence rates ... See more keywords
Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Nephrology"
DOI: 10.1159/000489964
Abstract: Background: Serum phosphate and vitamin D receptor activator regulate fibroblast growth factor 23 (FGF23), and iron may modulate FGF23 metabolism. The aim of the present study was to elucidate the effects of ferric citrate hydrate… read more here.
Keywords: hemodialysis; citrate; fibroblast growth; ferric citrate ... See more keywords
Real-World Phosphate Binder Use Among Dialysis-Dependent Patients With CKD.
Sign Up to like & getrecommendations! Published in 2023 at "Nephron"
DOI: 10.1159/000530230
Abstract: INTRODUCTION For patients with chronic kidney disease (CKD), the need for phosphate binder (PB) treatment peaks at onset of dialysis. This real-world study assessed rates of PB utilization and switching in patients with dialysis-dependent CKD… read more here.
Keywords: dialysis dependent; ferric citrate; dialysis; phosphate binder ... See more keywords
Segregating the effects of ferric citrate‐mediated iron utilization and FGF23 in a mouse model of CKD
Sign Up to like & getrecommendations! Published in 2022 at "Physiological Reports"
DOI: 10.14814/phy2.15307
Abstract: Ferric citrate (FC) is an approved therapy for chronic kidney disease (CKD) patients as a phosphate (Pi) binder for dialysis‐dependent CKD, and for iron deficiency anemia (IDA) in non‐dialysis CKD. Elevated Pi and IDA both… read more here.
Keywords: cre; fgf23; iron; ferric citrate ... See more keywords
Ferric citrate and ferric EDTA but not ferrous sulfate drive amphiregulin-mediated activation of the MAP kinase ERK in gut epithelial cancer cells
Sign Up to like & getrecommendations! Published in 2018 at "Oncotarget"
DOI: 10.18632/oncotarget.24899
Abstract: Ferric chelates may be used as oral iron supplements or phosphate binders but both ferric citrate and ferric EDTA have been shown to promote tumor burden in murine models of colon cancer. Here we studied… read more here.
Keywords: cancer; ferrous sulfate; ferric edta; ferric citrate ... See more keywords
Can ferric citrate lead to iron overload in peritoneal dialysis patients? .
Sign Up to like & getrecommendations! Published in 2020 at "Clinical nephrology"
DOI: 10.5414/cn109738
Abstract: Ferric citrate (FC), a novel oral phosphate binder, is approved by the U.S. Food and Drug Administration (FDA) for the treatment of hyperphosphatemia in end-stage renal disease (ESRD) patients receiving dialysis. FC binds to dietary… read more here.
Keywords: dialysis patients; peritoneal dialysis; dialysis; ferric citrate ... See more keywords